Thromb Haemost 2014; 111(01): 165-171
DOI: 10.1160/TH13-05-0433
New Technologies, Diagnostic Tools and Drugs
Schattauer GmbH

The effect of thrombus aspiration during primary percutaneous coronary intervention on clinical outcome in daily clinical practice

Sinem Kilic
1   Isala klinieken, Location Weezenlanden, Dept of Cardiologie, Zwolle, The Netherlands
,
Jan Paul Ottervanger
1   Isala klinieken, Location Weezenlanden, Dept of Cardiologie, Zwolle, The Netherlands
,
Jan-Henk E. Dambrink
1   Isala klinieken, Location Weezenlanden, Dept of Cardiologie, Zwolle, The Netherlands
,
Jan C. A. Hoorntje
1   Isala klinieken, Location Weezenlanden, Dept of Cardiologie, Zwolle, The Netherlands
,
Petra C. Koopmans
1   Isala klinieken, Location Weezenlanden, Dept of Cardiologie, Zwolle, The Netherlands
,
A. T. Marcel Gosselink
1   Isala klinieken, Location Weezenlanden, Dept of Cardiologie, Zwolle, The Netherlands
,
Harry Suryapranata
1   Isala klinieken, Location Weezenlanden, Dept of Cardiologie, Zwolle, The Netherlands
2   Universitair Medisch Centrum Nijmegen, Dept of Cardiology, Nijmegen, The Netherlands
,
Arnoud W. J. van ’t Hof
1   Isala klinieken, Location Weezenlanden, Dept of Cardiologie, Zwolle, The Netherlands
,
the Zwolle Myocardial Infarction Study Group › Author Affiliations
Further Information

Publication History

Received: 29 May 2013

Accepted after major revision: 22 August 2013

Publication Date:
29 November 2017 (online)

Summary

It was the purpose of this study to assess the effect of thrombus aspiration (TA) during primary percutaneous coronary intervention (PPCI) on reperfusion and clinical outcome in a real-world STEMI population. The decision to use TA (Export catheter, Medtronic) was at the discretion of the treating cardiologist. The primary endpoint was mortality at short (in-hospital) and long term (one year) follow-up. Secondary end points were post-PCI TIMI flow, residual ST deviation and enzymatic infarct size. Cox proportional hazard models (propensity-weighted) and logistic regression analysis were used to adjust for known covariates, associated with mortality. We performed a retrospective analysis of prospectively collected data on 2,552 consecutive PPCI-treated STEMI patients between 2007 and 2010. Use of TA increased from 6.9% in 2007 to 62.2% in 2010 (p<0.001). TA was performed in 899 patients (35.2%). In-hospital and one-year mortality rates were 3.0% and 6.0%, respectively, in the TA group and 3.5% and 7.6% in the no- TA group. After multivariate analysis, TA was not significantly associated with in-hospital mortality (adjusted odds ratio [OR]: 0.70; 95% confidence interval [CI]: 0.33–1.49, p=0.36) nor one year mortality (adjusted hazard ratio [HR]: 0.75, 95%CI: 0.47–1.20, p=0.23) or cardiac mortality (HR: 0.81; 95%CI: 0.45–1.46, p=0.49). After matching on the propensity score, the HR in the TA group for one year mortality was 0.70 (95%CI: 0.41–1.20, p=0.19) and for one-year cardiac mortality 0.70 (95%CI: 0.36–1.34, p=0.28). In conclusion, no significant relationship of TA with one of the secondary end points was found. The use of TA increased over the last years but clinical outcome was similar in both groups (TA vs no-TA) in this large cohort of real-world, unselected STEMI patients.

 
  • References

  • 1 Gu YL, Kampinga MA, Wieringa WG. et al. Intracoronary versus intravenous administartion of abciximab in patients with ST-Segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration. Circulation 2010; 122: 2709-2717.
  • 2 Vlaar PJ, Svilaas T, van der Horst ICC. et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 2008; 371: 1915-1920.
  • 3 Silva-Orrego P, Colombo P, Bigi R. et al. Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction: the DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) study. J Am Coll Cardiol 2006; 48: 1552-1559.
  • 4 Sardella G, Mancone M, Bucciarelli-Ducci C. et al. Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in in-farct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. J Am Coll Cardiol 2009; 53: 309-315.
  • 5 Burzotta F, De Vita M, Gu YL. et al. Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. Eur Heart J 2009; 30: 2193-2203.
  • 6 van’t Hof AWJ, Liem A, Suryapranata H. et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction. Circulation 1998; 97: 2302-2306.
  • 7 Svilaas T, Vlaar PJ, van der Horst ICC. et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008; 358: 557-567.
  • 8 Burzotta F, Trani C, Romagnoli E. et al. Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolisation by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J Am Coll Cardiol 2005; 46: 371-376.
  • 9 Srinivasan M, Rihal C, Holmes DR. et al. Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on micro-vascular perfusion and outcomes. Circulation 2009; 119: 1311-1319.
  • 10 De Luca G, Dudek D, Sardella G. et al. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. Eur Heart J 2012; 29: 3002-3010.
  • 11 Stone GW, Maehara A, Witzenbichler B. et al. INFUSE- AMI Investigators. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. J Am Med Assoc 2012; 307: 1817-1826.
  • 12 Fokkema ML, Vlaar PJ, Svilaas T. et al. Incidence and clinical consequences of distal embolisation on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction. Eur Heart J 2009; 30: 908-915.
  • 13 Kaltoft A, Böttcher M, Nielsen SS. et al. Routine thrombectomy in percutaneous coronary intervention for acute ST segment elevation myocardial infarction. Circulation 2006; 114: 40-47.
  • 14 Ali A, Cox D, Dib N. et al. AIMI Investigators. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myo-cardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol 2006; 48: 244-252.
  • 15 Noman A, Egred M, Bagnall A. et al. Impact of thrombus aspiration during primary percutaneous coronary intervention on mortality in ST-segment elevation myocardial infarction. Eur Heart J 2012; 33: 3054-3061.
  • 16 Galiuto L, Garramone B, Burzotta F. et al. Thrombus aspiration reduces micro-vascular obstruction after primary coronary intervention. A myocardial contrast echocardiography substudy of the REMEDIA Trial. J Am Coll Cardiol 2006; 48: 1355-1360.
  • 17 Bavry AA, Kumbhani DJ, Bhatt DL. Role of adjunctive thrombectomy and em-bolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. Eur Heart J 2008; 24: 2989-3001.
  • 18 Kramer MCA, van der Wal AC, Koch KT. et al. Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention. Circulation 2008; 118: 1810-1816.
  • 19 Liistro F, Grotti S, Angioli P. et al. Impact of thrombus aspiration on myocardial tissue reperfusion and left ventricular functional recovery and remodeling after primary angioplasty. Circulation 2009; 2: 376-383.
  • 20 Steg PG, James SK, Atar D. et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST- segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J 2012; 33: 2569-2619.
  • 21 Vlaar PJ, de Smet BJ, van den Heuvel AF. et al. Operator dependence of outcome after primary percutaneous coronary intervention. EuroIntervention 2011; 6: 760-767.